ESAOTE S.P.A.

Esaote S.p.A. is a global medical imaging manufacturer founded in the early 1980s, headquartered in Italy with significant operations in the United States (Fishers, IN). The company specializes in ultrasound systems, magnetic resonance imaging (MRI), and healthcare IT solutions. Their product portfolio includes advanced ultrasound platforms such as the MyLab series (MyLab E85 GTS, MyLab C30 GTS) featuring proprietary technologies like PAM (Photoacoustic Microscopy) for precision imaging across multiple clinical applications including cardiology, urology, and interventional radiology. Esaote also develops intraoperative MRI systems, exemplified by the I-Genius platform for neurosurgery. The company offers comprehensive healthcare IT and enterprise imaging solutions integrated with clinical workflows for prevention, diagnosis, therapy, and follow-up. Esaote serves hospitals, diagnostic imaging centers, and specialty practices globally. The company holds relevant regulatory certifications and maintains robust R&D capabilities focused on clinical needs and market trends. Esaote emphasizes customer care, technical support, and equipment performance optimization. The organization has achieved UNI/PdR 125:2022 gender equality certification and maintains commitment to sustainability and ESG principles. Recent strategic partnerships, such as with Schiller Americas for cardiology imaging expansion, reflect the company's growth trajectory in the North American market.